Clinical Trial Update: S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating megestrol acetate (Megace) for treating hot flashes in patients after breast cancer treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Megace (megestrol acetate)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer, Hot Flashes | Phase 3 | Status: COMPLETED